3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase NA
2
Phase 1
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
2
Classical hematology
1
Conditions
Skin Neoplasms
2
Myelodysplastic Syndromes
2
Prostatic Neoplasms
1
Neoplasms
1
Myofibroma
1
Multiple Endocrine Neoplasia Type 1
1
Motor Activity
1
Limb-girdle muscular dystrophy, type 2C
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Intraocular Lymphoma
1
Inflammation
1
Hemorrhage
1
Eye Diseases
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus
1
Cytopenia
1
Corneal Endothelial Cell Loss
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Cataract
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Adenomyosis
1
Interventions
Cyclophosphamide
15
Antilymphocyte Serum
11
fludarabine phosphate
10
Cyclosporine
9
Busulfan
9
Peripheral Blood Stem Cell Transplantation
8
Mycophenolic Acid
7
Filgrastim
7
Methotrexate
6
Whole-Body Irradiation
5
Melphalan
5
fludarabine
4
Radiotherapy
4
Methylprednisolone
4
Cord Blood Stem Cell Transplantation
4
Tacrolimus
3
Psychiatric Rehabilitation
3
Palliative Care
3
Blood Specimen Collection
3
sargramostim
2
Thiotepa
2
Therapeutics
2
Stem Cell Transplantation
2
Polymerase Chain Reaction
2
Injections
2
Granulocyte Colony-Stimulating Factor
2
Dexamethasone
2
Cytarabine
2
Behavior Therapy
2
Ascorbic Acid
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Myelodysplastic Syndromes
×
Ascorbic Acid
×
Clear all
NCT03682029
2024-04-17
EVITA
Rigshospitalet, Denmark
Phase NA
Unknown
109 enrolled
NCT02877277
2018-09-24
EVITA-Pilot
Rigshospitalet, Denmark
Phase NA
Completed
20 enrolled